Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Umei, Tomohiko C., Kishino, Yoshikazu, Watanabe, Keiko, Shiraishi, Yasuyuki, Inohara, Taku, Yuasa, Shinsuke, Fukuda, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656213/
https://www.ncbi.nlm.nih.gov/pubmed/34904134
http://dx.doi.org/10.1016/j.cjco.2021.12.002
Descripción
Sumario:COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus–induced myopericarditis and after a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.

Ejemplares similares